Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

10.66 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
LVWR Stock Alert: 7 Things to Know as LiveWire Starts Trading
LiveWire (LVWR) stock is in the news Wednesday as the electric motorcycle company makes its trading debut today after a SPAC merger. 
Via InvestorPlace
Why Is Prothena (PRTA) Stock Up 75% Today?
Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company. 
Via InvestorPlace
Stocks Take Another Stab At Rebound As Bond Yields Soften
Stocks are making another attempt to rebound on Wednesday, with the Dow Jones Industrial Average and S&P 500 Index both up roughly 1% at the midway mark. 
Via Talk Markets
How Is The Market Feeling About Prothena Corp?
Prothena Corp's (NASDAQ:PRTA) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 2.46 million shares sold short, which is 13.83% of all regular... 
Via Benzinga
US Stocks Mixed; Wholesale Inventories Increase 1.3% In August
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. 
Via Benzinga
Recap: Prothena Corp Q2 Earnings
  Prothena Corp (NASDAQ:PRTA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Prothena Corporation plc (NASDAQ: PRTA)  
Via Benzinga
Recap: Prothena Corp Q4 Earnings
Prothena Corp (NASDAQ:PRTA) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
What's Going On With Prothena Stock Up Over 60% Today
Prothena Corporation PLC (NASDAQ: PRTA) shares are trading higher by 61.27% to $49.88 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. 
Via InvestorPlace
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
Via Benzinga
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session. 
Via Benzinga
Prothena Corp's Return On Capital Employed Overview
Prothena Corp (NASDAQ:PRTA) brought in sales totaling $1.31 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 13.65%, resulting in a loss of $41.24 million. 
Via Benzinga
Jim Cramer Says This Company Is A Great One
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield. 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For August 8, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
Via Benzinga
A Preview Of Prothena Corp's Earnings
Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp... 
Via Benzinga
Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock
RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading. 
Via Benzinga
Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease
Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate... 
Via Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO... 
Via Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
Why Jim Cramer Prefers This Mining Stock Over Vale
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc. (NYSE: 
Via Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio... 
Via Benzinga
4 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.